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A NUMBER of compounds which readily induce tumours in some other species
of rodent fail to do so in the guinea-pig, and apart from some early papillomas
observed after two years' treatment with benzo[a]pyrene (Oberling et al., 1937)
the only carcinogen so far reported to be active on skin application to guinea-pigs
is 7,12-dimethylbenzo[a]anthracene (DMBA) (Berenblum, 1949; Edgcomb and
Mitchelich. 1963).
We have now found. however, that a variety of tumours can be induced in the
guinea-pig by skin applications of the carcinogens 3-propiolactone (BPL) and 4-
nitroquinoline N-oxide (NQO), provided treatment is continued for two or more
years. The experiments are described in this paper, and the results are discussed
in relation to " species resistance " and carcinogen metabolism.
EXPERIMENTAL
Jlaterials
BPL (L. Light & Co.) was distilled under reduced pressure and applied in dry
purified acetone as described by Searle (1961), and the NQO was used in acetone
as described by Searle and Woodhouse (1964). Benzene was dried with potassiunm
carbonate and redistilled.
Anirnals
Guinea-pigs were obtained from the Department of Pharmacology, University
of Birmingham; their sex and colour were as shown in Table I. They were
housed on sawdust in open runs, and were fed pellet diet SG. 1 and cabbage with
free access to tap water.
The compounds were applied to four clipped areas, each about 3 sq. in. in
area, on the front and rear flanks of each animal. Hair growth was slow on
sites treated with NQO, but BPL-treated animals needed weekly clipping.
Treatment
At first, BPL was applied twice weekly to two diagonally opposite sites in 2 5
per cent solution (v/v) and to the other two sites in 5 0 per cent solution. The
standard volume was 0 5 ml. per site. Though Roe and Glendenning (1956)
found that 5-10 per cent BPL in acetone caused ulceration and scarring of mouse
skin, we found no such effect on our guinea-pigs, and after a few months the 5 per
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cent solution was used on all four sites. However, 5 per cent BPL in benzene
proved too irritating, and the two animals treated with this solution for 5 weeks
were, after a short break, transferred to the 5 per cent solution in acetone.
NQO was applied initially at 0-5 per cent in acetone to two diagonally opposite
sites, and at 10 per cent to the other two sites, using 0 5 ml. per site twice weekly as
with BPL. As was found when using lower concentrations of NQO in mice (as
yet unpublished, Searle and Spencer), symptoms indicating a toxic effect gradually
developed. A number of breaks in NQO treatment were therefore made to allow
recovery, and after about 18 months of intermittent treatment, applications were
continued at the two strengths on the right sites only.
Two animals on each compound died during the first year of treatment. The
maximum period of survival from the start of treatment was 168 weeks with BPL
and 134 weeks with NQO. Biopsies of skin lesions were carried out under ether
anaesthesia on one BPL guinea-pig after 99 weeks, and on 3 NQO animals after 80,
103 and 119 weeks. Animals which died or were killed owing to poor condition
were dissected, and treated skin, skin lesions and organs showing abnormal
appearances were fixed (4 per cent formaldehyde-saline) and stained for histo-
logical examination with Ehrlich's haematoxylin-eosin and Weigert's iron haema-
toxylin-Van Gieson's stain. Suspected melanoma tissue was also stained by
Masson's Fontana method. Details of these animals, their treatment and results
are summarised in Table I.
TABLE I.-Application of 3-Propiolactone and 4-Nitroquinoline N-Oxide to Guinea-
Pig Skin: Summary of Treatment and Results.
Animal
and
sex*
1 F.
10 Al.
15 F.*t
9 M.*
Biopsy I
(weeks) (
99
f/-Propiolactonie in
acetone
4-Nitroquinolino
N-oxide
in acetone
1 4 M.
1 3 F.*
I 11 Al.
14 AT.t
2 F.
13 F.
5 F.
12 F.
17 M.*
7 F.
6 F.
16 M.t
F.
80
103
119
Death
weeks)
38
46
Pathology
85 Widespread pigmented naevi.
Keratoacanthoma; pigmented intra-
dermal naevi.
141 Keratoacanthoma; benign intra-
dermrral naevi; hepatoma; ma,lig-
nant tumour oflacrimal gland.
107 Keratoacanthoma.
119 Very slight dermal naevi.
127 .
127 Melanoma; keratin cysts; early naevi.
168
2
17
56
. Sarcoma.
126 4 Keratoacanthomas.
2 Trichoepitheliomas; keratin cyst.
123 3 Amelanotic melanomas; metastases
to lung and lymph nodes.
112
Compound junctional naevus.
128 2 Keratoacanthomas.
134 Lymph node tumour; keratin cyst.
* The numbers are arbitrary numbers given to individual animals. Guinea-Pig No. 15 was brown
anld No. 17 black. All others were white with pink eyes except No. 3 and 9 which had dark eyes.
t Treated initially with benzene solutions of carcinogens.
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RESULTS
As will be seen by reference to Table I, the commonest tumour was the kerato-
acanthoma. This tumour was induced by both BPL and NQO. Examples
varied in complexity from simple squamous cysts to complex, flask-shapedtumours
showing atypical squamous epithelial differentiation (Fig. 1-4). The range of
appearances was similar to those described by other workers in a variety ofspecies
and using different carcinogenic agents (e.g. Ghadially, 1958, 1959, 1960; Howell,
1962).
Perhaps the most interesting tumours were those derived from pigment cells or
melanocytes. These tumours are of particular pathological interest because the
details of normal skin pigmentation in the guinea-pig (unlike many other com-
monly used experimental animals) closely resemble those ofman, and furthermore
the pigmented tumours produced in the guinea-pig resemble quite closely certain
spontaneous tumours in man. In normal guinea-pig skin melanocytes are confined
to the basal epidermal layers as in man. The first stage in tumour development
appears to be a proliferation of these cells both in surface epidermis and in the
stratified epithelium forming the hair follicles. Later, cells invade the dermis and
in some examples activity inthe basal epidermal layers may notbe evident. These
stages in development produce tumours which we have described as junctional,
compound or intradermal pigmented naevi because of their similarity to the
equivalent lesions in man (Fig. 5-7).
Malignant tumours ofpigment cell origin-described as melanomas-have been
separated from the previous tumours mainly on the basis of distinctive cytology,
the component cells being much larger with an open nuclear pattern andfrequently
with a prominent eosinophilic nucleolus. Some examples show striking pleo-
morphism (Fig. 8 and 9). In these experiments only one such tumour was shown
to be biologically malignant by the demonstration of metastases (Fig. 10-12) but
in other experiments with DMBA a similar histological picture was also associated
with metastases (Parish, 1963).
EXPLANATION OF PLATES
FIG. 1.-Flask-shaped keratoacanthoma at top. More complex epidermal cyst at bottom.
H.&E. x10.
FIG. 2.-Superficial part of large epidermoid cyst lined by regular squamous epithelium.
H&E. x10.
FIG. 3.-Complex, multi-locular keratoacanthoma. H. & E. x 10.
FIG. 4.-Deep aspect of keratoacanthoma impinging on muscle layer. " Sebaceous " struc-
tures are frequently present in the cyst lining. H. & E. x 25.
FIG. 5.-Junctional naevus with groups of clear cells forming in the lower layers of the epi-
dermis. At lower left is part ofthe wall of an epidermoid cyst. H. & E. x 100.
FIG. 6.-Detail of junctional activity. Packages of naevus cells are beginning to invade the
dermis. H. & E. X 250.
FIG. 7.-Early compound naevus. Melanin is present in tumour cells and melanophages in the
dermal component. Masson's Fontana. x 125.
FIG. 8.-Margin of malignant melanoma. A compound naevus is present in the upper right
hand corner. H. & E. x 10.
FIG. 9.-Pleomorphic cytology ofmalignant melanoma with large nuclei containing prominent
(eosinophilic) nucleoli. H. & E. x 250.
FIG. 10.-Metastasis from melanoma in lymph node. H. & E. x 100.
FIG. 11.-Metastases from melanoma in lung. H. & E. x 10.
FIG. 12.-Bizarre cytology of lung metastasis. H. & E. x 60.
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Other isolated tumours which occurred in these animals included a hepatoma,
a tumour of lacrimal gland, an undifferentiated skin tumour regarded as sarcoma,
and a lymph node tumour which had histological appearances resembling secondary
amelanotic melanoma, although we were unable to demonstrate a convincing
primary skin tumour.
DISCUSSION
In addition to its resistance to carcinogenesis by the polycyclic hydrocarbon
carcinogens, referred to earlier in relation to skin carcinogenesis, the guinea-pig is
resistant to various other agents which induce tumours in other rodents under
suitable conditions. These include 2-amino- and 2-acetamido-fluorene (Weis-
burger and Weisburger, 1958), urethane (Cowen, 1950) and implanted plastic film
(Stinson, 1960). There are also reports on the rarity of spontaneous tumours in
the guinea-pig (Warren and Gates, 1941; Lombard, 1960; Mosinger, 1961).
However, a number of comparative studies on the metabolism of carcinogens
suggest that the difference in response of the guinea-pig to some carcinogens com-
pared with, e.g., the mouse may be attributable to differences in the way the
substances are transported and metabolised rather than to an ill-defined " cancer
resistance " in the guinea-pig.
In the case of the polycyclic hydrocarbon carcinogens, Chevallier, Manuel and
Denoix (1946) noted that subcutaneously injected 3-methyleholanthrene and
benzo[a]pyrene rapidly disappeared from the injection site in the guinea-pig,
though they were detectable for many months in the rat. More recently, quan-
titative determinations of the amounts of carcinogenic hydrocarbons retained in
the skin of different species two hours after application (Bock, 1963) have shown
that guinea-pig skin retains much smaller amounts of the compounds than do
mouse, rat and hamster skin. Bock's finding that DMBA was retained in con-
siderably larger amounts than benzopyrene or methylcholanthrene accords with
the fact that only DMBA has so far proved carcinogenic for guinea-pig skin.
Differences in the hydroxylation products of 2-acetamidofluorene formed in
the guinea-pig and other species were demonstrated by Weisburger, Weisburger
and Morris (1958), and the resistance of the guinea-pig to this carcinogen may be
due to its failure to form the N-hydroxy metabolite (Miller, Cramer and Miller
1960). This type of compound, which is a substituted hydroxylamine, R.NHOH,
may also be responsible for the activity of other aromatic amine carcinogens, a
possibility discussed by Clayson (1964).
It is similarly possible that the hydroxylamine derivative of NQO, 4-hydroxy-
aminoquinoline N-oxide, formed in this case as one stage in the metabolic reduction
ofthe nitro group, is ofimportance in NQO carcinogenesis, since it has been shown
to be carcinogenic for mice on subcutaneous injection (Shirasu, 1963). That we
have now found NQO to induce tumours in the guinea-pig does not conflict with
the inactivity of acetamidofluorene because of the different modes of formation of
the N-hydroxy metabolites in the two cases. Our results contrast, however, with
those of Shirasu (1962) who obtained only one tumour after treating guinea-pigs
with NQO by subcutaneous injection for up to 30 months.
The outstanding feature of the chemical behaviour of NQO is its extremely
ready reaction in neutral solution with thiol-containing compounds, in which the
labile nitro group is eliminated as nitrite (Okabayashi, 1953 ; Endo, 1958; Searle
and Woodhouse, 1963). The failure ofNQO to react under similar conditions with
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thiol-free compounds, in particular with nucleic acid derivatives, appears to favour
the importance of metabolic reduction in NQO carcinogenesis, though the direct
NQO-thiol reaction may well be responsible for the toxic effects observed by
other workers and ourselves.
Unlike NQO, BPL reacts with a wide variety of organic groupings. It readily
alkylates not only thiol groups, yielding for example S-2-carboxyethylcysteine by
reaction with cysteine (Dickens and Jones, 1961), but also the 7-position ofguanine
derivatives (Roberts and Warwick, 1963), and there is now strong evidence
linking the alkylation ofguanine in mouse skin DNA by BPL with its carcinogenic
action (Colburn and Boutwell, 1965). Other alkylating agents may thus also
prove carcinogenic for the guinea-pig, provided that tests are continued long
enough to allow for the longer life-span and generally slower rate of tumour
development in this species. Diethylnitrosamine, which probably owes its
carcinogenicity to alkylation ofguanine by a metabolite (see, e.g., Magee and Lee,
1964), has in fact already been shown to be carcinogenic for the guinea-pig by
Druckrey and Steinhoff (1962) and Argus and Hoch-Ligeti (1963).
The carcinogenicity of diethylnitrosamine, BPL and NQO for the guinea-pig,
coupled with the results ofthe metabolic experiments referred to earlier, now form
a strong body ofevidence that the guinea-pig is not inherently resistant to chemical
carcinogenesis. Its apparent resistance to some agents is due to its relatively
slow rate of tumour development, to rapid elimination of some carcinogens or to
failure to form carcinogenic metabolites.
The guinea-pig differs nevertheless from other generally used experimental
animals in details of normal skin pigmentation and of pigmented tumours, which
bear a close resemblance to those seen in man. This feature, described in the
Results section, makes the guinea-pig a potentially useful model for the study of
melanotic tumours of the type which occur in man.
SUMMARY
1. The carcinogens /3-propiolactone and 4-nitroquinoline N-oxide have been
applied for long periods to the skin of guinea-pigs.
2. Some guinea-pigs treated with each compound eventually developed pig-
mented or non-pigmented lesions ofthe skin. One animal treated with the lactone
had an extensive hepatoma.
3. The results are discussed with regard to carcinogen metabolism and the
resistance of the guinea-pig to some carcinogens.
4. The similarity in the pigmentation of normal skin and pigmented tumours
between the guinea-pig and man is emphasised.
The work was supported by the Birmingham Branch of the British Empire
Cancer Campaign for Research.
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